The fourth HIV epidemic

Gabrièle Laborde-Balen, Bernard Taverne, Cheikh Tidiane Ndour, Charles Kouanfack, Martine Peeters, Ibra Ndoye, Eric Delaporte

In The Lancet Infectious Diseases, Ravindra Gupta and colleagues1 present alarming results on the development of pre-treatment viral resistance to the most commonly used drugs to treat HIV infection in resource-limited countries.

Assessing TB infection control practices in Malawi: research application and implications for the regional response

Tingathe Outreach Program, Baylor College of Medicine Children's Foundation-Malawi

Tuberculosis (TB) is the 9th leading cause of death worldwide.1 While TB mortality and incidence are decreasing, there are still significant gaps in detection and treatment.2 One in four new TB cases occurred in Africa in 2016, and co-infection with HIV is a notab

The Challenge of a Changing HIV Epidemic

Robert Kueffer

We have come a long way in our response to the HIV epidemic since its beginning. Many critical steps have been made. In the last seven years, new HIV infection rates have dropped almost 30 percent worldwide.

Why Finding New HIV Targets Takes So Long: Some Basics About Basic Research

Christy Gaines

Although great strides have been made at combating human immunodeficiency virus, leading to better quality of life and a longer life expectancy for those living with the

New Findings Presented at IAS 2017 Reveal More about the Inter-relationship Between the Microbiome and HIV

Jeannie Wraight

Over the past several years, research has uncovered just how important the microbiome is to human health.

Making the case for asking key populations about violence: A success story from South Sudan

Kim Dixon, GBV consultant, LINKAGES

Before joining the LINKAGES project, I spent most of my career developing, managing, and evaluating gender-based violence (GBV) prevention and response programs for women and girls in emergency, post-conflict, and development settings, as well as in the U.S.

How to effectively and meaningfully engage communities in differentiated service delivery

Solange Baptiste, Executive Director at the International Treatment Preparedness Coalition (ITPC)

There is a clear appreciation for the pivotal role that communities have played in the HIV response over the last 32 years, but it’s no surprise that critical gaps remain – particularly with respect to the ways communities are effectively and meaningfully engaged in their care and treatment.

HIV Self-testing Offers New Opportunities for Health Workers and Lay Providers

Cheryl Johnson, Technical Officer, World Health Organization

Long-Acting Injectable Antiretrovirals for PrEP: Will the tail wag the drug?

Mark Mascolini and Emily Bass

Mark Mascolini is a medical journalist who writes about HIV news, research and global policies for the International AIDS Society and many publications. Emily Bass is the Director of Strategy & Content at AVAC.